Literature DB >> 16770313

Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.

M G Guttridge1, C Sidders, E Booth-Davey, D Pamphilon, S M Watt.   

Abstract

The COBE Spectra is used to volume/red blood cell (RBC) deplete BM before transplantation or cryopreservation. We have audited our results to identify the effect of transit time, refrigerated storage, age and cellular composition on mononuclear cells (MNC) and CD34+ cell recoveries, volume/RBC depletion and neutrophil engraftment. In total, 88 consecutive collections from autologous (n = 25) and allogeneic (n = 63) donors were included. The mean collection volume was 1250 +/- 398 ml with RBC content of 341 +/- 113 ml. The MNC and CD34+ cell recoveries were 83.3 +/- 18.5 and 88.1 +/- 18.9%, respectively, volume depletion was 88.2+/-4.4% and RBC depletion 98.3 +/- 1.8%. Neutrophil engraftment was achieved in 20.1 +/- 6.4 days. Factors affecting MNC and CD34+ cell recoveries were transit time (P = 0.0060), overall age (P < 0.0210) and MNC/CD34+ cell concentrations (P < 0.0313). The presence of crenated RBC also reduced CD34+ cell recovery (P = 0.0028). Refrigerated storage did not adversely affect cell recovery (P > 0.8161) or neutrophil engraftment (P = 0.8959). This study demonstrates that time in transit, overall age, MNC and CD34+ cell concentrations and RBC condition were important factors affecting processing. RBCs show artefacts soon after collection at ambient temperatures and these may interfere with the separation and collection of MNC/CD34+ cells. Refrigeration at 4-6 degrees C during transit and storage may reduce formation of RBC artefacts and maximize MNC and CD34+ cell recoveries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770313     DOI: 10.1038/sj.bmt.1705420

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  8 in total

Review 1.  The processing of stem cell concentrates from the bone marrow in ABO-incompatible transplants: how and when.

Authors:  Nicola Daniele; Maria Cristina Scerpa; Cecilia Rossi; Alessandro Lanti; Gaspare Adorno; Giancarlo Isacchi; Francesco Zinno
Journal:  Blood Transfus       Date:  2013-11-21       Impact factor: 3.443

2.  RBC depletion from a PBSC graft.

Authors:  H Bonig; G Bug
Journal:  Bone Marrow Transplant       Date:  2017-04-24       Impact factor: 5.483

Review 3.  Donor selection in T cell-replete haploidentical hematopoietic stem cell transplantation: knowns, unknowns, and controversies.

Authors:  Stefan O Ciurea; Richard E Champlin
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-11       Impact factor: 5.742

4.  Donor and recipient age, gender and ABO incompatibility regardless of donor source: validated criteria for donor selection for haematopoietic transplants.

Authors:  Y Wang; D-P Wu; Q-F Liu; L-P Xu; K-Y Liu; X-H Zhang; Y Xu; F Huang; X-J Huang
Journal:  Leukemia       Date:  2017-06-23       Impact factor: 11.528

5.  Challenges of Cellular Therapy During the COVID-19 Pandemic.

Authors:  Kamal Kant Sahu; Sikander Ailawadhi; Natalie Malvik; Jan Cerny
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

6.  Storage of hemopoietic stem cells.

Authors:  Derwood Pamphilon; Aleksandar Mijovic
Journal:  Asian J Transfus Sci       Date:  2007-07

7.  Erythrocyte depletion from bone marrow: performance evaluation after 50 clinical-scale depletions with Spectra Optia BMC.

Authors:  Soo-Zin Kim-Wanner; Gesine Bug; Juliane Steinmann; Salem Ajib; Nadine Sorg; Carolin Poppe; Milica Bunos; Eva Wingenfeld; Christiane Hümmer; Beate Luxembourg; Erhard Seifried; Halvard Bonig
Journal:  J Transl Med       Date:  2017-08-11       Impact factor: 5.531

Review 8.  How do we choose the best donor for T-cell-replete, HLA-haploidentical transplantation?

Authors:  Ying-Jun Chang; Leo Luznik; Ephraim J Fuchs; Xiao-Jun Huang
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.